Skip to main content

Safety of Metronidazole in Late Pre-term and Term Infants with Complicated Intra-abdominal Infections.

Publication ,  Journal Article
Commander, SJ; Gao, J; Zinkhan, EK; Heresi, G; Courtney, SE; Lavery, AP; Delmore, P; Sokol, GM; Moya, F; Benjamin, D; Bumpass, TG; Debski, J ...
Published in: Pediatr Infect Dis J
September 2020

BACKGROUND: Metronidazole is frequently used off-label in infants with complicated intra-abdominal infections (cIAI) to provide coverage against anaerobic organisms, but its safety and efficacy in this indication are unknown. METHODS: In the Antibiotic Safety in Infants with Complicated Intra-Abdominal Infections open-label multicenter trial infants ≥34 weeks gestation at birth and <121 days postnatal age with cIAIs were administered metronidazole as part of multimodal therapy. Metronidazole safety was evaluated by reporting of adverse events (AEs) and safety events of special interest. Cure from disease was determined by blood cultures and a clinical cure score >4. A blinded adjudication committee reviewed all safety events of special interest. RESULTS: Fifty-five infants were included, median gestational age was 36 weeks (range: 34-41) and postnatal age was 7 days (0-63). The most common additional antibiotics received included gentamicin, piperacillin-tazobactam, ampicillin and vancomycin. Only one AE, a candidal rash, was identified to be potentially caused by metronidazole administration. One infant died of cardiopulmonary failure, which was deemed unrelated to metronidazole. The most common events of special interest included feeding intolerance in 18 (33%) infants, and exploratory laparotomy in 10 (18%) requiring intestinal anastomosis in 7 (13%) infants. There was 1 (2%) intestinal stricture. Fifty-three infants (96%) achieved overall therapeutic success, 54 (98%) were alive through 30 days post-study therapy, and 54 (98%) had 30-day clinical cure score >4. CONCLUSIONS: In a cohort of late pre-term and term infants with cIAIs, combination antibiotic therapy that included metronidazole was safe, and therapeutic success was high.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Pediatr Infect Dis J

DOI

EISSN

1532-0987

Publication Date

September 2020

Volume

39

Issue

9

Start / End Page

e245 / e248

Location

United States

Related Subject Headings

  • United States
  • Pediatrics
  • Metronidazole
  • Male
  • Intraabdominal Infections
  • Infant, Newborn
  • Infant
  • Humans
  • Gestational Age
  • Female
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Commander, S. J., Gao, J., Zinkhan, E. K., Heresi, G., Courtney, S. E., Lavery, A. P., … Best Pharmaceuticals for Children Act—Pediatric Trials Network Steering Committee. (2020). Safety of Metronidazole in Late Pre-term and Term Infants with Complicated Intra-abdominal Infections. Pediatr Infect Dis J, 39(9), e245–e248. https://doi.org/10.1097/INF.0000000000002698
Commander, Sarah Jane, Jamie Gao, Erin K. Zinkhan, Gloria Heresi, Sherry E. Courtney, Adrian P. Lavery, Paula Delmore, et al. “Safety of Metronidazole in Late Pre-term and Term Infants with Complicated Intra-abdominal Infections.Pediatr Infect Dis J 39, no. 9 (September 2020): e245–48. https://doi.org/10.1097/INF.0000000000002698.
Commander SJ, Gao J, Zinkhan EK, Heresi G, Courtney SE, Lavery AP, et al. Safety of Metronidazole in Late Pre-term and Term Infants with Complicated Intra-abdominal Infections. Pediatr Infect Dis J. 2020 Sep;39(9):e245–8.
Commander, Sarah Jane, et al. “Safety of Metronidazole in Late Pre-term and Term Infants with Complicated Intra-abdominal Infections.Pediatr Infect Dis J, vol. 39, no. 9, Sept. 2020, pp. e245–48. Pubmed, doi:10.1097/INF.0000000000002698.
Commander SJ, Gao J, Zinkhan EK, Heresi G, Courtney SE, Lavery AP, Delmore P, Sokol GM, Moya F, Benjamin D, Bumpass TG, Debski J, Erinjeri J, Sharma G, Tracy ET, Smith PB, Cohen-Wolkowiez M, Hornik CP, Best Pharmaceuticals for Children Act—Pediatric Trials Network Steering Committee. Safety of Metronidazole in Late Pre-term and Term Infants with Complicated Intra-abdominal Infections. Pediatr Infect Dis J. 2020 Sep;39(9):e245–e248.

Published In

Pediatr Infect Dis J

DOI

EISSN

1532-0987

Publication Date

September 2020

Volume

39

Issue

9

Start / End Page

e245 / e248

Location

United States

Related Subject Headings

  • United States
  • Pediatrics
  • Metronidazole
  • Male
  • Intraabdominal Infections
  • Infant, Newborn
  • Infant
  • Humans
  • Gestational Age
  • Female